Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucocorticoid-remediable aldosteronism.

Graham T McMahon1, Robert G Dluhy

  • 1Division of Endocrinology, Diabetes & Hypertension, Brigham & Women's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA. gmcmahon@partners.org

Cardiology in Review
|December 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing Professionalism in Continuing Education: Development and Early Outcomes of Accreditation Council for Continuing Medical Education Certificate Assessments.

The Journal of continuing education in the health professions·2026
Same author

When the Algorithm Teaches-Promise and Peril of AI in Physician Learning.

JAMA·2026
Same author

Accredited Continuing Medical Education Delivers: Evidence of Value, Trust, and Impact Across the Healthcare System.

Journal of CME·2025
Same author

Principles to award learning achievements for lifelong learning in health using micro-credentials: an international Delphi study.

Human resources for health·2025
Same author

Transforming Continuing Professional Development for Healthcare Professionals to Meet National Goals in Saudi Arabia.

Journal of CME·2024
Same author

International Medical Graduates and the Physician Workforce.

JAMA·2024

Glucocorticoid remediable aldosteronism (GRA) is a common genetic hypertension. This condition causes ectopic aldosterone synthesis, leading to high blood pressure and increased risk of cerebral hemorrhage.

Area of Science:

  • Endocrinology
  • Genetics
  • Cardiovascular Medicine

Background:

  • Glucocorticoid remediable aldosteronism (GRA) is the most prevalent monogenic hypertension.
  • It results from a chimeric gene duplication, causing ectopic aldosterone synthesis in the adrenal zona fasciculata.
  • Aldosterone production is inappropriately stimulated by adrenocorticotropin (ACTH).

Purpose of the Study:

  • To summarize the key features of Glucocorticoid remediable aldosteronism.
  • To highlight the clinical presentation and complications of GRA.
  • To emphasize the importance of identifying affected individuals for targeted management.

Main Methods:

  • Review of existing literature on Glucocorticoid remediable aldosteronism.
  • Analysis of clinical manifestations and genetic basis of GRA.

Related Experiment Videos

  • Discussion of diagnostic and therapeutic implications.

    • Main Results:

    • GRA patients typically present with hypertension, often early in life.
    • They show resistance to common antihypertensives like ACE inhibitors and beta-blockers.
    • Normokalemic individuals may develop hypokalemia with potassium-wasting diuretics.
    • A significant prevalence of early-onset cerebral hemorrhage, often due to aneurysms, is observed.

    Conclusions:

    • Early identification of GRA is crucial for initiating targeted antihypertensive therapy.
    • Neurovascular screening is recommended for affected individuals due to aneurysm risk.
    • Understanding GRA's pathophysiology aids in managing this monogenic form of hypertension.